rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Klaus Schafer

Director

Company insider

Files Form 4 as: Director, Altimmune.

Every Form 4 they filed

In numbers

Trades disclosed
26
Buys
1
Sells
1
Bought
$24K
Sold
$101K
Companies
1
Companies where not an officer
1
First trade
4 May 2017
Last trade
1 May 2026
Last filed
1 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ALT AltimmuneDirector · Biotechnology · last 1 May 20261 buy · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 May 2026filed 1 May 2026ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—48,800 at $0.00filing
1 May 2026filed 1 May 2026ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—48,800 at $0.00filing
25 Sep 2025filed 29 Sep 2025ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—48,800 at $0.00filing
26 Sep 2024filed 30 Sep 2024ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—34,900 at $0.00filing
28 Sep 2023filed 29 Sep 2023ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—26,100 at $0.00filing
29 Sep 2022filed 30 Sep 2022ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—23,500 at $0.00filing
20 Jun 2022filed 22 Jun 2022ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code M—60 at $0.00filing
20 Jun 2022filed 22 Jun 2022ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code M—159 at $0.00filing
20 Jun 2022filed 22 Jun 2022ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code M—60 at $0.00filing
20 Jun 2022filed 22 Jun 2022ALT AltimmuneBiotechnologySEC FORM 4 Code M$14460 at $2.40filing
20 Jun 2022filed 22 Jun 2022ALT AltimmuneBiotechnologySEC FORM 4 Code M$382159 at $2.40filing
20 Jun 2022filed 22 Jun 2022ALT AltimmuneBiotechnologySEC FORM 4 Code M$14460 at $2.40filing
23 Sep 2021filed 24 Sep 2021ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—24,100 at $0.00filing
10 Dec 2020filed 11 Dec 2020ALT AltimmuneBiotechnologySEC FORM 4 Bought$24K2,000 at $11.99filing
12 Nov 2020filed 13 Nov 2020ALT AltimmuneBiotechnologySEC FORM 4 Sold$101K10,150 at $9.91filing
24 Sep 2020filed 16 Oct 2020ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code M—16,850 at $0.00filing
24 Sep 2020filed 16 Oct 2020ALT AltimmuneBiotechnologySEC FORM 4 Code M—16,850 at $0.00filing
24 Sep 2020filed 28 Sep 2020ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—25,500 at $0.00filing
25 Jun 2020filed 29 Jun 2020ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code C—16,850 at $0.00filing
2 Jan 2019filed 4 Jan 2019ALT Altimmuneoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Gregory L. WeaverChief Financial Officer · Chief Financial Officer at Altimmune, filing Form 4 there in the last year
Christophe Arbet-EngelsChief Medical Officer · Chief Medical Officer at Altimmune, filing Form 4 there in the last year
Richard Thomas MenziusoPrincipal Accounting Officer · Principal Accounting Officer at Altimmune, filing Form 4 there in the last year
Linda M. RichardsonChief Commercial Officer · Chief Commercial Officer at Altimmune, filing Form 4 there in the last year
Jerome Benedict DursoPresident and CEO · President and CEO at Altimmune, filing Form 4 there in the last year